Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 6 of 6  Show

Literature citations Results

An extended association screen in multiple sclerosis using 202 microsatellite markers targeting apoptosis-related genes does not reveal new predisposing factors.

Godde R., Brune S., Jagiello P., Sindern E., Haupts M., Schimrigk S., Muller N., Epplen J.T.

J Negat Results Biomed 4:7-7(2005) · Mapped (11)

Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips.

Godde R., Rohde K., Becker C., Toliat M.R., Entz P., Suk A., Muller N., Sindern E., Haupts M., Schimrigk S. et al.

J. Mol. Med. 83:486-494(2005) · Mapped (1,488)

The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.

Zuechner S., Vorgerd M., Sindern E., Schroeder J.M.

Neuromuscul. Disord. 14:147-157(2004) · UniProtKB (1) · Mapped (1)

Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations.

Miterski B., Bohringer S., Klein W., Sindern E., Haupts M., Schimrigk S., Epplen J.T.

Genes Immun. 3:211-219(2002) · Mapped (2)

PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients.

Miterski B., Sindern E., Haupts M., Schimrigk S., Epplen J.T.

BMC Med. Genet. 3:3-3(2002) · Mapped (17)

Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease.

Ziemssen F., Sindern E., Schroder J.M., Shin Y.S., Zange J., Kilimann M.W., Malin J.P., Vorgerd M.

Ann. Neurol. 47:536-540(2000) · UniProtKB (1)

1 to 6 of 6  Show